Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI model that was developed by Isomorphic Labs and Google DeepMind. According to ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...

This Collection supports and amplifies research related to SDG 3: Good Health & Wellbeing and SDG 17: Partnerships for the Goals. The rapid evolution of artificial intelligence (AI) is reshaping the ...

Discover how researchers are overcoming the limitations of the undruggable target in drug discovery using novel approaches ...

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

(Reuters) -U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical, deepening their use of artificial intelligence ...

In biology, many RNA molecules act as sophisticated microscopic machines. Among them, riboswitches function as tiny biological sensors, changing their 3D shape upon binding to a specific metabolite.